Answer
Stopping Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Gilead in patients coinfected with HIV and hepatitis B may cause severe acute exacerbations of hepatitis, which may lead to hepatic decompensation in patients with advanced liver disease or cirrhosis.
Sources for this answer
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Gilead150 mg/150 mg/200 mg/245 mg film-coated tabletsGilead Sciences Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 32Document updated
Sources checked